Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells - Role of mitogen activated protein kinase and phosphatidylinositol 3-kinase

被引:98
作者
Niculescu, F
Badea, T
Rus, H
机构
[1] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA
[2] Med Clin 1, Cluj Napoca 3400, Romania
关键词
aortic smooth muscle cells; cell cycle; terminal complement complexes; mitogen activated protein kinase; phosphatidylinositol; 3-kinase;
D O I
10.1016/S0021-9150(98)00185-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Proliferation of vascular smooth muscle cells contributes to initimal hyperplasia during atherogenesis, but the factors regulating their proliferation are not well known. In the present study we report that sublytic C5b-9 assembly induced proliferation of differentiated human aortic smooth muscle cells (ASMC) in culture. Cell cycle re-entry occurred through activation of cdk4, cdk2 kinase and the reduction of p21 cell cycle inhibitor. We also investigated if C5b-9 cell cycle induction is mediated through activation of mitogen activated protein kinase (MAPK) pathways. Extracellular signal regulated kinase (ERK) 1 activity was significantly increased, while c-jun NH,(2)-terminal kinase (JNK) 1 and p38 MAPK activity were only transiently increased. Pretreatment with wortmannin inhibits ERK1 activation by C5b-9, suggesting the involvement of phosphatidylinositol 3-kinase (PI 3-kinase). Both PI 3-kinase and p70 S6 kinase were activated by C5b-9 but not by C5b6. C5b-9 induced DNA. synthesis was abolished by pretreatment with inhibitors of ERK1 and PI 3-kinase, but not by p38 MAPK. These data indicated that ERK1 and PI 3-kinase play a major role in C5b-9 induced ASMC proliferation. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:47 / 56
页数:10
相关论文
共 44 条
[1]   TERMINAL COMPLEMENT PROTEINS C5B-9 RELEASE BASIC FIBROBLAST GROWTH-FACTOR AND PLATELET-DERIVED GROWTH-FACTOR FROM ENDOTHELIAL-CELLS [J].
BENZAQUEN, LR ;
NICHOLSONWELLER, A ;
HALPERIN, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (03) :985-992
[2]  
BHAKDI S, 1995, J EXP MED, V182, P1959, DOI 10.1084/jem.182.6.1959
[3]  
CARNEY DF, 1990, J IMMUNOL, V145, P623
[4]   ADENOVIRUS-MEDIATED OVER-EXPRESSION OF THE CYCLIN CYCLIN-DEPENDENT KINASE INHIBITOR, P21 INHIBITS VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION AND NEOINTIMA FORMATION IN THE RAT CAROTID-ARTERY MODEL OF BALLOON ANGIOPLASTY [J].
CHANG, MW ;
BARR, E ;
LU, MM ;
BARTON, K ;
LEIDEN, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) :2260-2268
[5]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[6]   TRANSFORMING G-PROTEIN-COUPLED RECEPTORS POTENTLY ACTIVATE JNK (SAPK) - EVIDENCE FOR A DIVERGENCE FROM THE TYROSINE KINASE SIGNALING PATHWAY [J].
COSO, OA ;
CHIARIELLO, R ;
KALINEC, G ;
KYRIAKIS, JM ;
WOODGETT, J ;
GUTKIND, JS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (10) :5620-5624
[7]  
DISCIPIO RG, 1983, J BIOL CHEM, V258, P629
[8]   Cell cycle regulation of p70 S6 kinase and p42/p44 mitogen-activated protein kinases in Swiss mouse 3T3 fibroblasts [J].
Edelmann, HML ;
Kuhne, C ;
Petritsch, C ;
Ballou, LM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) :963-971
[9]  
ELDEIRY WS, 1994, CANCER RES, V54, P1169
[10]   THE IMPLICATIONS OF ANGIOGENESIS FOR THE BIOLOGY AND THERAPY OF CANCER METASTASIS [J].
FIDLER, IJ ;
ELLIS, LM .
CELL, 1994, 79 (02) :185-188